Request for Covid-19 Impact Assessment of this Report
The United States Enteric-coated Tablets market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Enteric-coated Tablets market, reaching US$ million by the year 2028. As for the Europe Enteric-coated Tablets landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Enteric-coated Tablets players cover Bayer, Weidar Chemical & Pharmaceutical, AstraZeneca, and Boehringer Ingelheim, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Enteric-coated Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Aspirin
Serrapeptase
Bisacodyl
Esomeprazole Magnesium
Pantoprazole Sodium
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer
Weidar Chemical & Pharmaceutical
AstraZeneca
Boehringer Ingelheim
Takeda
Novartis
Dr. Reddy's Laboratories
GSK
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Enteric-coated Tablets Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Enteric-coated Tablets by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Enteric-coated Tablets by Country/Region, 2017, 2022 & 2028
2.2 Enteric-coated Tablets Segment by Type
2.2.1 Aspirin
2.2.2 Serrapeptase
2.2.3 Bisacodyl
2.2.4 Esomeprazole Magnesium
2.2.5 Pantoprazole Sodium
2.3 Enteric-coated Tablets Sales by Type
2.3.1 Global Enteric-coated Tablets Sales Market Share by Type (2017-2022)
2.3.2 Global Enteric-coated Tablets Revenue and Market Share by Type (2017-2022)
2.3.3 Global Enteric-coated Tablets Sale Price by Type (2017-2022)
2.4 Enteric-coated Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Enteric-coated Tablets Sales by Application
2.5.1 Global Enteric-coated Tablets Sale Market Share by Application (2017-2022)
2.5.2 Global Enteric-coated Tablets Revenue and Market Share by Application (2017-2022)
2.5.3 Global Enteric-coated Tablets Sale Price by Application (2017-2022)
3 Global Enteric-coated Tablets by Company
3.1 Global Enteric-coated Tablets Breakdown Data by Company
3.1.1 Global Enteric-coated Tablets Annual Sales by Company (2020-2022)
3.1.2 Global Enteric-coated Tablets Sales Market Share by Company (2020-2022)
3.2 Global Enteric-coated Tablets Annual Revenue by Company (2020-2022)
3.2.1 Global Enteric-coated Tablets Revenue by Company (2020-2022)
3.2.2 Global Enteric-coated Tablets Revenue Market Share by Company (2020-2022)
3.3 Global Enteric-coated Tablets Sale Price by Company
3.4 Key Manufacturers Enteric-coated Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enteric-coated Tablets Product Location Distribution
3.4.2 Players Enteric-coated Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Enteric-coated Tablets by Geographic Region
4.1 World Historic Enteric-coated Tablets Market Size by Geographic Region (2017-2022)
4.1.1 Global Enteric-coated Tablets Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Enteric-coated Tablets Annual Revenue by Geographic Region
4.2 World Historic Enteric-coated Tablets Market Size by Country/Region (2017-2022)
4.2.1 Global Enteric-coated Tablets Annual Sales by Country/Region (2017-2022)
4.2.2 Global Enteric-coated Tablets Annual Revenue by Country/Region
4.3 Americas Enteric-coated Tablets Sales Growth
4.4 APAC Enteric-coated Tablets Sales Growth
4.5 Europe Enteric-coated Tablets Sales Growth
4.6 Middle East & Africa Enteric-coated Tablets Sales Growth
5 Americas
5.1 Americas Enteric-coated Tablets Sales by Country
5.1.1 Americas Enteric-coated Tablets Sales by Country (2017-2022)
5.1.2 Americas Enteric-coated Tablets Revenue by Country (2017-2022)
5.2 Americas Enteric-coated Tablets Sales by Type
5.3 Americas Enteric-coated Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enteric-coated Tablets Sales by Region
6.1.1 APAC Enteric-coated Tablets Sales by Region (2017-2022)
6.1.2 APAC Enteric-coated Tablets Revenue by Region (2017-2022)
6.2 APAC Enteric-coated Tablets Sales by Type
6.3 APAC Enteric-coated Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Enteric-coated Tablets by Country
7.1.1 Europe Enteric-coated Tablets Sales by Country (2017-2022)
7.1.2 Europe Enteric-coated Tablets Revenue by Country (2017-2022)
7.2 Europe Enteric-coated Tablets Sales by Type
7.3 Europe Enteric-coated Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Enteric-coated Tablets by Country
8.1.1 Middle East & Africa Enteric-coated Tablets Sales by Country (2017-2022)
8.1.2 Middle East & Africa Enteric-coated Tablets Revenue by Country (2017-2022)
8.2 Middle East & Africa Enteric-coated Tablets Sales by Type
8.3 Middle East & Africa Enteric-coated Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enteric-coated Tablets
10.3 Manufacturing Process Analysis of Enteric-coated Tablets
10.4 Industry Chain Structure of Enteric-coated Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enteric-coated Tablets Distributors
11.3 Enteric-coated Tablets Customer
12 World Forecast Review for Enteric-coated Tablets by Geographic Region
12.1 Global Enteric-coated Tablets Market Size Forecast by Region
12.1.1 Global Enteric-coated Tablets Forecast by Region (2023-2028)
12.1.2 Global Enteric-coated Tablets Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Enteric-coated Tablets Forecast by Type
12.7 Global Enteric-coated Tablets Forecast by Application
13 Key Players Analysis
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Enteric-coated Tablets Product Offered
13.1.3 Bayer Enteric-coated Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Weidar Chemical & Pharmaceutical
13.2.1 Weidar Chemical & Pharmaceutical Company Information
13.2.2 Weidar Chemical & Pharmaceutical Enteric-coated Tablets Product Offered
13.2.3 Weidar Chemical & Pharmaceutical Enteric-coated Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Weidar Chemical & Pharmaceutical Main Business Overview
13.2.5 Weidar Chemical & Pharmaceutical Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca Enteric-coated Tablets Product Offered
13.3.3 AstraZeneca Enteric-coated Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Enteric-coated Tablets Product Offered
13.4.3 Boehringer Ingelheim Enteric-coated Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Enteric-coated Tablets Product Offered
13.5.3 Takeda Enteric-coated Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Enteric-coated Tablets Product Offered
13.6.3 Novartis Enteric-coated Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Dr. Reddy's Laboratories
13.7.1 Dr. Reddy's Laboratories Company Information
13.7.2 Dr. Reddy's Laboratories Enteric-coated Tablets Product Offered
13.7.3 Dr. Reddy's Laboratories Enteric-coated Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Dr. Reddy's Laboratories Main Business Overview
13.7.5 Dr. Reddy's Laboratories Latest Developments
13.8 GSK
13.8.1 GSK Company Information
13.8.2 GSK Enteric-coated Tablets Product Offered
13.8.3 GSK Enteric-coated Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GSK Main Business Overview
13.8.5 GSK Latest Developments
14 Research Findings and Conclusion
Table 1. Enteric-coated Tablets Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Enteric-coated Tablets Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Aspirin
Table 4. Major Players of Serrapeptase
Table 5. Major Players of Bisacodyl
Table 6. Major Players of Esomeprazole Magnesium
Table 7. Major Players of Pantoprazole Sodium
Table 8. Global Enteric-coated Tablets Sales by Type (2017-2022) & (K Units)
Table 9. Global Enteric-coated Tablets Sales Market Share by Type (2017-2022)
Table 10. Global Enteric-coated Tablets Revenue by Type (2017-2022) & ($ million)
Table 11. Global Enteric-coated Tablets Revenue Market Share by Type (2017-2022)
Table 12. Global Enteric-coated Tablets Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Enteric-coated Tablets Sales by Application (2017-2022) & (K Units)
Table 14. Global Enteric-coated Tablets Sales Market Share by Application (2017-2022)
Table 15. Global Enteric-coated Tablets Revenue by Application (2017-2022)
Table 16. Global Enteric-coated Tablets Revenue Market Share by Application (2017-2022)
Table 17. Global Enteric-coated Tablets Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Enteric-coated Tablets Sales by Company (2020-2022) & (K Units)
Table 19. Global Enteric-coated Tablets Sales Market Share by Company (2020-2022)
Table 20. Global Enteric-coated Tablets Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Enteric-coated Tablets Revenue Market Share by Company (2020-2022)
Table 22. Global Enteric-coated Tablets Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Enteric-coated Tablets Producing Area Distribution and Sales Area
Table 24. Players Enteric-coated Tablets Products Offered
Table 25. Enteric-coated Tablets Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Enteric-coated Tablets Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Enteric-coated Tablets Sales Market Share Geographic Region (2017-2022)
Table 30. Global Enteric-coated Tablets Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Enteric-coated Tablets Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Enteric-coated Tablets Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Enteric-coated Tablets Sales Market Share by Country/Region (2017-2022)
Table 34. Global Enteric-coated Tablets Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Enteric-coated Tablets Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Enteric-coated Tablets Sales by Country (2017-2022) & (K Units)
Table 37. Americas Enteric-coated Tablets Sales Market Share by Country (2017-2022)
Table 38. Americas Enteric-coated Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Enteric-coated Tablets Revenue Market Share by Country (2017-2022)
Table 40. Americas Enteric-coated Tablets Sales by Type (2017-2022) & (K Units)
Table 41. Americas Enteric-coated Tablets Sales Market Share by Type (2017-2022)
Table 42. Americas Enteric-coated Tablets Sales by Application (2017-2022) & (K Units)
Table 43. Americas Enteric-coated Tablets Sales Market Share by Application (2017-2022)
Table 44. APAC Enteric-coated Tablets Sales by Region (2017-2022) & (K Units)
Table 45. APAC Enteric-coated Tablets Sales Market Share by Region (2017-2022)
Table 46. APAC Enteric-coated Tablets Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Enteric-coated Tablets Revenue Market Share by Region (2017-2022)
Table 48. APAC Enteric-coated Tablets Sales by Type (2017-2022) & (K Units)
Table 49. APAC Enteric-coated Tablets Sales Market Share by Type (2017-2022)
Table 50. APAC Enteric-coated Tablets Sales by Application (2017-2022) & (K Units)
Table 51. APAC Enteric-coated Tablets Sales Market Share by Application (2017-2022)
Table 52. Europe Enteric-coated Tablets Sales by Country (2017-2022) & (K Units)
Table 53. Europe Enteric-coated Tablets Sales Market Share by Country (2017-2022)
Table 54. Europe Enteric-coated Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Enteric-coated Tablets Revenue Market Share by Country (2017-2022)
Table 56. Europe Enteric-coated Tablets Sales by Type (2017-2022) & (K Units)
Table 57. Europe Enteric-coated Tablets Sales Market Share by Type (2017-2022)
Table 58. Europe Enteric-coated Tablets Sales by Application (2017-2022) & (K Units)
Table 59. Europe Enteric-coated Tablets Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Enteric-coated Tablets Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Enteric-coated Tablets Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Enteric-coated Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Enteric-coated Tablets Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Enteric-coated Tablets Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Enteric-coated Tablets Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Enteric-coated Tablets Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Enteric-coated Tablets Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Enteric-coated Tablets
Table 69. Key Market Challenges & Risks of Enteric-coated Tablets
Table 70. Key Industry Trends of Enteric-coated Tablets
Table 71. Enteric-coated Tablets Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Enteric-coated Tablets Distributors List
Table 74. Enteric-coated Tablets Customer List
Table 75. Global Enteric-coated Tablets Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Enteric-coated Tablets Sales Market Forecast by Region
Table 77. Global Enteric-coated Tablets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Enteric-coated Tablets Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Enteric-coated Tablets Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Enteric-coated Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Enteric-coated Tablets Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Enteric-coated Tablets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Enteric-coated Tablets Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Enteric-coated Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Enteric-coated Tablets Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Enteric-coated Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Enteric-coated Tablets Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Enteric-coated Tablets Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Enteric-coated Tablets Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Enteric-coated Tablets Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Enteric-coated Tablets Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Enteric-coated Tablets Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Enteric-coated Tablets Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Enteric-coated Tablets Revenue Market Share Forecast by Application (2023-2028)
Table 95. Bayer Basic Information, Enteric-coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 96. Bayer Enteric-coated Tablets Product Offered
Table 97. Bayer Enteric-coated Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Bayer Main Business
Table 99. Bayer Latest Developments
Table 100. Weidar Chemical & Pharmaceutical Basic Information, Enteric-coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 101. Weidar Chemical & Pharmaceutical Enteric-coated Tablets Product Offered
Table 102. Weidar Chemical & Pharmaceutical Enteric-coated Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Weidar Chemical & Pharmaceutical Main Business
Table 104. Weidar Chemical & Pharmaceutical Latest Developments
Table 105. AstraZeneca Basic Information, Enteric-coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 106. AstraZeneca Enteric-coated Tablets Product Offered
Table 107. AstraZeneca Enteric-coated Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. AstraZeneca Main Business
Table 109. AstraZeneca Latest Developments
Table 110. Boehringer Ingelheim Basic Information, Enteric-coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 111. Boehringer Ingelheim Enteric-coated Tablets Product Offered
Table 112. Boehringer Ingelheim Enteric-coated Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Boehringer Ingelheim Main Business
Table 114. Boehringer Ingelheim Latest Developments
Table 115. Takeda Basic Information, Enteric-coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 116. Takeda Enteric-coated Tablets Product Offered
Table 117. Takeda Enteric-coated Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Takeda Main Business
Table 119. Takeda Latest Developments
Table 120. Novartis Basic Information, Enteric-coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 121. Novartis Enteric-coated Tablets Product Offered
Table 122. Novartis Enteric-coated Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Novartis Main Business
Table 124. Novartis Latest Developments
Table 125. Dr. Reddy's Laboratories Basic Information, Enteric-coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 126. Dr. Reddy's Laboratories Enteric-coated Tablets Product Offered
Table 127. Dr. Reddy's Laboratories Enteric-coated Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Dr. Reddy's Laboratories Main Business
Table 129. Dr. Reddy's Laboratories Latest Developments
Table 130. GSK Basic Information, Enteric-coated Tablets Manufacturing Base, Sales Area and Its Competitors
Table 131. GSK Enteric-coated Tablets Product Offered
Table 132. GSK Enteric-coated Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. GSK Main Business
Table 134. GSK Latest Developments
List of Figures
Figure 1. Picture of Enteric-coated Tablets
Figure 2. Enteric-coated Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enteric-coated Tablets Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Enteric-coated Tablets Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Enteric-coated Tablets Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Aspirin
Figure 10. Product Picture of Serrapeptase
Figure 11. Product Picture of Bisacodyl
Figure 12. Product Picture of Esomeprazole Magnesium
Figure 13. Product Picture of Pantoprazole Sodium
Figure 14. Global Enteric-coated Tablets Sales Market Share by Type in 2021
Figure 15. Global Enteric-coated Tablets Revenue Market Share by Type (2017-2022)
Figure 16. Enteric-coated Tablets Consumed in Hospital
Figure 17. Global Enteric-coated Tablets Market: Hospital (2017-2022) & (K Units)
Figure 18. Enteric-coated Tablets Consumed in Clinic
Figure 19. Global Enteric-coated Tablets Market: Clinic (2017-2022) & (K Units)
Figure 20. Global Enteric-coated Tablets Sales Market Share by Application (2017-2022)
Figure 21. Global Enteric-coated Tablets Revenue Market Share by Application in 2021
Figure 22. Enteric-coated Tablets Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Enteric-coated Tablets Revenue Market Share by Company in 2021
Figure 24. Global Enteric-coated Tablets Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Enteric-coated Tablets Revenue Market Share by Geographic Region in 2021
Figure 26. Global Enteric-coated Tablets Sales Market Share by Region (2017-2022)
Figure 27. Global Enteric-coated Tablets Revenue Market Share by Country/Region in 2021
Figure 28. Americas Enteric-coated Tablets Sales 2017-2022 (K Units)
Figure 29. Americas Enteric-coated Tablets Revenue 2017-2022 ($ Millions)
Figure 30. APAC Enteric-coated Tablets Sales 2017-2022 (K Units)
Figure 31. APAC Enteric-coated Tablets Revenue 2017-2022 ($ Millions)
Figure 32. Europe Enteric-coated Tablets Sales 2017-2022 (K Units)
Figure 33. Europe Enteric-coated Tablets Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Enteric-coated Tablets Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Enteric-coated Tablets Revenue 2017-2022 ($ Millions)
Figure 36. Americas Enteric-coated Tablets Sales Market Share by Country in 2021
Figure 37. Americas Enteric-coated Tablets Revenue Market Share by Country in 2021
Figure 38. United States Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Enteric-coated Tablets Sales Market Share by Region in 2021
Figure 43. APAC Enteric-coated Tablets Revenue Market Share by Regions in 2021
Figure 44. China Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Enteric-coated Tablets Sales Market Share by Country in 2021
Figure 51. Europe Enteric-coated Tablets Revenue Market Share by Country in 2021
Figure 52. Germany Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Enteric-coated Tablets Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Enteric-coated Tablets Revenue Market Share by Country in 2021
Figure 59. Egypt Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Enteric-coated Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Enteric-coated Tablets in 2021
Figure 65. Manufacturing Process Analysis of Enteric-coated Tablets
Figure 66. Industry Chain Structure of Enteric-coated Tablets
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...